UNSPSC 51132228: Aspirin/butalbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

UNSPSC 51132228 Aspirin/butalbital is a Commodity code that captures pharmaceutical products and over-the-counter medications purchased by state and local health agencies, typically through competitive bidding or cooperative purchasing vehicles. Recent solicitations under this code show state and local governments buying a mix of generic multi-source pharmaceuticals, naloxone kits, drug deactivation systems, and OTC products for community health programs, emergency response, and institutional pharmacy supply. The issuing bodies include county health departments, state health and human services commissions, and multi-state cooperative purchasing alliances that aggregate demand across state and local facilities. Vendors must meet federal and state compliance requirements including cGMP certification, Drug Supply Chain Security Act adherence, E-Verify employment verification, and proof of authorization from the FDA; many solicitations require insurance coverage (workers' compensation, general liability, professional liability) and mandate supply relationships with established pharmaceutical wholesalers. Contracts typically run two years with renewal options and include probationary periods; pricing is often structured as fixed-fee or net-price formats, with administrative fees of three percent on purchases.

The code shows activity across multiple states, with recent solicitations posted by Minnesota (through the Minnesota Multistate Cooperative Purchasing Alliance), Texas (HHS Commission), and Florida (Seminole County). The Minnesota MMCAP RFP, issued January 20, 2026 with a response deadline of March 26, 2026, seeks generic pharmaceuticals and OTC products for distribution across participating state and local government facilities in multiple states including Oregon, with awards effective July 1, 2026. Seminole County, Florida released an IFB (No. IFB60459723LAS) on June 30, 2026 to procure 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries, with bids due July 26, 2023. The Texas Health and Human Services Commission posted a Request for Information on April 3, 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program, signaling early-stage procurement planning that may lead to larger formal solicitations. State and local procurement under this code remains steady but fragmented across individual counties and multi-state cooperative vehicles, with no indication of federal set-aside designations in the recent opportunities.